WASHINGTON -- In the third year of COVID-19, people still struggle to return to normalcy in their daily lives. How will vaccines and testing be administered, and how will the economy and education be affected?
Nikkei recently spoke with virologist Robert Redfield, who served as director of the U.S. Centers for Disease Control and Prevention during the Trump administration and is now senior medical advisor to Virginia-based public health firm AM LLC, to get a better look at the path ahead.
